Neoantigen-based Personalized DNA Vaccine in Patients With Newly Diagnosed, Unmethylated Glioblastoma
Clinical trial NCT04015700 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04015700
- Sponsor
- Washington University School of Medicine
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-14
- Primary completion
- 2022-05-13
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.